AbbVie Stock (ABBV) – Trade Alert In The Stock Sell-Off – Jan 28 2019

AbbVie Stock (ABBV)

The latest earnings released on Jan 25 definitely disappointed investors and analysts. The expectations were for a $1.94 in earnings. The company was short 4 cents at $1.90. However it was up from last year $1.48 and revenue was higher at $8.3 billion for the quarter versus $7.7 billion last year for the same quarter.

Investors and analysts are not happy with the quarterly results and with news from the company that they expect steeper decline in Humira’s overseas sales.

Here are the trades I have started this morning within the stock.

. This AbbVie Stock (ABBV) article is for FullyInformed Members.

 AbbVie Stock (ABBV) – Trade Alert In The Stock Sell-Off – Jan 28 2019

Disclaimer: There are risks involved in all investment strategies and investors can and do lose capital. You trade at your own risk. The author assumes no liability for your investment decisions. Read the full disclaimer.

Internal Stock and Option Trades Links

Portfolio Listing by Years

My Principal Stocks Index

Trade Ideas for Members

Trade Alerts for Members

Put Selling Strategies

Put Selling Strategies For Members

Covered Calls Strategies

Covered Calls Strategies For Members

Profit And Income Strategies Index

Stock and Option Strategies For Members

Stock And Option Trades Explained For Members

Ask A Question About A Trade You Are In

Sign My Guestbook

Visit My Shop

Join The Free Options Forum